Patents by Inventor Hemant Kumar Misra

Hemant Kumar Misra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized anti-hepatitis B (HBV) antibody formulations
    Patent number: 8580256
    Abstract: The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.
    Type: Grant
    Filed: June 23, 2010
    Date of Patent: November 12, 2013
    Assignee: Yeda Reseach and Development Company Limited
    Inventors: Shlomo Dagan, Rachel Eren, Hemant Kumar Misra, Walter G. Gowan, Jr., Sandra O'Connor
  • STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS
    Publication number: 20100330099
    Abstract: The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.
    Type: Application
    Filed: June 23, 2010
    Publication date: December 30, 2010
    Applicant: YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED
    Inventors: Shlomo Dagan, Rachel Eren, Hemant Kumar Misra, Walter G. Gowan, JR., Sandra O'Connor
  • Stabilized anti-hepatitis B (HBV) antibody formulations
    Patent number: 7785595
    Abstract: The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: August 31, 2010
    Assignee: Yeda Research and Development Company Limited
    Inventors: Shlomo Dagan, Rachel Eren, Hemant Kumar Misra, Walter G. Gowan, Jr., Sandra O'Connor
  • Stabilized Anti-Hepatitis B (Hbv) Antibody Formulations
    Publication number: 20080152658
    Abstract: The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.
    Type: Application
    Filed: April 18, 2005
    Publication date: June 26, 2008
    Inventors: Shlomo Dagan, Rachel Eren, Hemant Kumar Misra, Walter G. Gowan, Sandra O'Connor